Skip to main content
. 2020 Aug 20;54(4):748–751. doi: 10.1016/j.jmii.2020.07.011

Table 1.

Reviewed patients’ characteristics and clinical manifestations (n = 92).

Variables Number (% except for age)
Median age (range, years) 66 (16–92)
Male gender (%) 50 (54)
Smoking history
 Current smoker 5 (5)
 Ex-smoker 17 (18)
 Never smoker 36 (39)
 Unknown 34 (37)
Infectious routes
 Cruise ship 25 (27)
 Music club, bar, night club 3 (3)
 Travel history 6 (7)
 Nursing home 10 (11)
 Sick contact 28 (30)
 Other 2 (2)
 Unknown 21 (23)
Underlying diseases (n = 90)
 Any 60 (67)
 Heart disease 7 (8)
 Chronic respiratory disease 10 (11)
 Diabetes mellitus 18 (20)
 Malignancy 11 (12)
 Chronic kidney disease 4 (4)
 Chronic hepatic disease 4 (4)
 Hypertension 32 (36)
 Hyperlipidemia 14 (16)
 Cerebrovascular disease 8 (9)
 Collagen vascular disease 4 (4)
Symptoms on diagnosis
 Fever (≧37.5 °C) 66 (72)
 Cough 37 (40)
 Sputum 4 (4)
 Sorethroat 15 (16)
 Runny nose 9 (10)
 Dyspnea 13 (14)
 General fatigue 33 (36)
 Headache 5 (5)
 Anorexia 10 (11)
 Diarrhea 10 (11)
 Stomachache 2 (2)
 Consciousness disturbance 2 (2)
 Nausea/vomit 5 (5)
 Headache 13 (14)
 Taste disorder 5 (5)
 Olfactory disorder 3 (3)
Respiratory rate ≧22 (/min) 10/69 (14)
Respiratory failure [SpO2<90% (room air)] 11/90 (12)
Fine crackles on ausculations 10/68 (15)
Treatment (n = 82)
 Prednisolone 16 (20)
 Hydroxychloroquine 11 (13)
 Lopinavir/ritonavir, 28 (34)
 Macrolides 16 (20)
 Neuraminidase inhibitors 7 (9)
 Ciclesonide, 26 (32)
 Camostat 5 (6)
 Nafamostat 2 (2)
 Favipiravir 18 (22)
 Baloxavir 2 (2)
 Kampo medicine 6 (7)
 Sivelestat 3 (4)
 Hemodialysis 2 (2)
 Intravenous immunoglobulin 3 (4)
Intratracheal intubation and mechanical ventilation 14 (17)
Outcome (n = 65)
Survival 61 (94)
Death 4 (6)

SpO2, oxygen saturation.

Twenty-seven patients moved to other institutes or under treatment.